Lang F - Search Results

1

Identification of neoantigens for individualized therapeutic cancer vaccines.

Lang F, Schrörs B, Löwer M, Türeci Ö, Sahin U. Lang F, et al. Nat Rev Drug Discov. 2022 Apr;21(4):261-282. doi: 10.1038/s41573-021-00387-y. Epub 2022 Feb 1. Nat Rev Drug Discov. 2022. PMID: 35105974 Free PMC article. Review.

2

NeoFox: annotating neoantigen candidates with neoantigen features.

Lang F, Riesgo-Ferreiro P, Löwer M, Sahin U, Schrörs B. Lang F, et al. Bioinformatics. 2021 Nov 18;37(22):4246-4247. doi: 10.1093/bioinformatics/btab344. Bioinformatics. 2021. PMID: 33970219 Free PMC article.

3

Accurate detection of tumor-specific gene fusions reveals strongly immunogenic personal neo-antigens.

Weber D, Ibn-Salem J, Sorn P, Suchan M, Holtsträter C, Lahrmann U, Vogler I, Schmoldt K, Lang F, Schrörs B, Löwer M, Sahin U. Weber D, et al. Among authors: lang f. Nat Biotechnol. 2022 Aug;40(8):1276-1284. doi: 10.1038/s41587-022-01247-9. Epub 2022 Apr 4. Nat Biotechnol. 2022. PMID: 35379963 Free PMC article.

4

MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expression.

Schrörs B, Hos BJ, Yildiz IG, Löwer M, Lang F, Holtsträter C, Becker J, Vormehr M, Sahin U, Ossendorp F, Diken M. Schrörs B, et al. Among authors: lang f. Front Immunol. 2023 Mar 8;14:1102282. doi: 10.3389/fimmu.2023.1102282. eCollection 2023. Front Immunol. 2023. PMID: 36969213 Free PMC article.

5

Multiple instance learning to predict immune checkpoint blockade efficacy using neoantigen candidates.

Lang F, Sorn P, Schrörs B, Weber D, Kramer S, Sahin U, Löwer M. Lang F, et al. iScience. 2023 Sep 22;26(11):108014. doi: 10.1016/j.isci.2023.108014. eCollection 2023 Nov 17. iScience. 2023. PMID: 37965155 Free PMC article.

6

Author Correction: Identification of neoantigens for individualized therapeutic cancer vaccines.

Lang F, Schrörs B, Löwer M, Türeci Ö, Sahin U. Lang F, et al. Nat Rev Drug Discov. 2024 Feb;23(2):156. doi: 10.1038/s41573-023-00873-5. Nat Rev Drug Discov. 2024. PMID: 38086950 No abstract available.

7

Prediction of tumor-specific splicing from somatic mutations as a source of neoantigen candidates.

Lang F, Sorn P, Suchan M, Henrich A, Albrecht C, Köhl N, Beicht A, Riesgo-Ferreiro P, Holtsträter C, Schrörs B, Weber D, Löwer M, Sahin U, Ibn-Salem J. Lang F, et al. Bioinform Adv. 2024 May 29;4(1):vbae080. doi: 10.1093/bioadv/vbae080. eCollection 2024. Bioinform Adv. 2024. PMID: 38863673 Free PMC article.

8

Artificial intelligence and neoantigens: paving the path for precision cancer immunotherapy.

Bulashevska A, Nacsa Z, Lang F, Braun M, Machyna M, Diken M, Childs L, König R. Bulashevska A, et al. Among authors: lang f. Front Immunol. 2024 May 29;15:1394003. doi: 10.3389/fimmu.2024.1394003. eCollection 2024. Front Immunol. 2024. PMID: 38868767 Free PMC article. Review.

9

CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy.

Billmeier A, Khinvasara K, Lang F, Mohr J, Reidenbach D, Schork M, Yildiz I, Diken M. Billmeier A, et al. Among authors: lang f. Hum Vaccin Immunother. 2022 Dec 31;18(1):2024416. doi: 10.1080/21645515.2021.2024416. Epub 2022 Feb 7. Hum Vaccin Immunother. 2022. PMID: 35130105 Free PMC article.

10

Long non-coding RNA LINC01224 plays an oncogenic role in endometrial cancer via miR-4673/TPX2 axis and activating Wnt/β-catenin signaling pathway.

Lv S, Zhang X, Lang F, Wu Y, Zhang C, Qi Q, Jiang J. Lv S, et al. Among authors: lang f. Biofactors. 2025 Jan-Feb;51(1):e2153. doi: 10.1002/biof.2153. Biofactors. 2025. PMID: 39780463

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,580 results

Search Page

Filters